BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

343 related articles for article (PubMed ID: 35215988)

  • 1. Influenza A(H1N1)pdm09 Virus but Not Respiratory Syncytial Virus Interferes with SARS-CoV-2 Replication during Sequential Infections in Human Nasal Epithelial Cells.
    Fage C; Hénaut M; Carbonneau J; Piret J; Boivin G
    Viruses; 2022 Feb; 14(2):. PubMed ID: 35215988
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Coinfection by Severe Acute Respiratory Syndrome Coronavirus 2 and Influenza A(H1N1)pdm09 Virus Enhances the Severity of Pneumonia in Golden Syrian Hamsters.
    Zhang AJ; Lee AC; Chan JF; Liu F; Li C; Chen Y; Chu H; Lau SY; Wang P; Chan CC; Poon VK; Yuan S; To KK; Chen H; Yuen KY
    Clin Infect Dis; 2021 Jun; 72(12):e978-e992. PubMed ID: 33216851
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Thapsigargin Is a Broad-Spectrum Inhibitor of Major Human Respiratory Viruses: Coronavirus, Respiratory Syncytial Virus and Influenza A Virus.
    Al-Beltagi S; Preda CA; Goulding LV; James J; Pu J; Skinner P; Jiang Z; Wang BL; Yang J; Banyard AC; Mellits KH; Gershkovich P; Hayes CJ; Nguyen-Van-Tam J; Brown IH; Liu J; Chang KC
    Viruses; 2021 Feb; 13(2):. PubMed ID: 33546185
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Relationships between A(H1N1)pdm09 influenza infection and infections with other respiratory viruses.
    Meningher T; Hindiyeh M; Regev L; Sherbany H; Mendelson E; Mandelboim M
    Influenza Other Respir Viruses; 2014 Jul; 8(4):422-30. PubMed ID: 24698156
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Heterogeneity in transmissibility and shedding SARS-CoV-2 via droplets and aerosols.
    Chen PZ; Bobrovitz N; Premji Z; Koopmans M; Fisman DN; Gu FX
    Elife; 2021 Apr; 10():. PubMed ID: 33861198
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Respiratory Syncytial Virus Protects Bystander Cells against Influenza A Virus Infection by Triggering Secretion of Type I and Type III Interferons.
    Czerkies M; Kochańczyk M; Korwek Z; Prus W; Lipniacki T
    J Virol; 2022 Nov; 96(22):e0134122. PubMed ID: 36326278
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluation of Three Multiplex Real-time Reverse Transcription PCR Assays for Simultaneous Detection of SARS-CoV-2, Influenza A/B, and Respiratory Syncytial Virus in Nasopharyngeal Swabs.
    Yun J; Park JH; Kim N; Roh EY; Shin S; Yoon JH; Kim TS; Park H
    J Korean Med Sci; 2021 Dec; 36(48):e328. PubMed ID: 34904407
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Influenza A and Respiratory Syncytial Virus Trigger a Cellular Response That Blocks Severe Acute Respiratory Syndrome Virus 2 Infection in the Respiratory Tract.
    Dee K; Schultz V; Haney J; Bissett LA; Magill C; Murcia PR
    J Infect Dis; 2023 Jun; 227(12):1396-1406. PubMed ID: 36550077
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Host Response to Influenza A Virus Interferes with SARS-CoV-2 Replication during Coinfection.
    Oishi K; Horiuchi S; Minkoff JM; tenOever BR
    J Virol; 2022 Aug; 96(15):e0076522. PubMed ID: 35862681
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical and virological impact of single and dual infections with influenza A (H1N1) and SARS-CoV-2 in adult inpatients.
    Zheng J; Chen F; Wu K; Wang J; Li F; Huang S; Lu J; Huang J; Liu H; Zhou R; Huang Z; Meng B; Yuan Z; Wu X
    PLoS Negl Trop Dis; 2021 Nov; 15(11):e0009997. PubMed ID: 34843492
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Interactions Between Severe Acute Respiratory Syndrome Coronavirus 2 Replication and Major Respiratory Viruses in Human Nasal Epithelium.
    Pizzorno A; Padey B; Dulière V; Mouton W; Oliva J; Laurent E; Milesi C; Lina B; Traversier A; Julien T; Trouillet-Assant S; Rosa-Calatrava M; Terrier O
    J Infect Dis; 2022 Dec; 226(12):2095-2104. PubMed ID: 36031537
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Epidemiological investigation of lower respiratory tract infections during influenza A (H1N1) pdm09 virus pandemic based on targeted next-generation sequencing.
    Li X; Liu Y; Li M; Bian J; Song D; Liu C
    Front Cell Infect Microbiol; 2023; 13():1303456. PubMed ID: 38162581
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Long-Term Modeling of SARS-CoV-2 Infection of
    Hao S; Ning K; Kuz CA; Vorhies K; Yan Z; Qiu J
    mBio; 2020 Nov; 11(6):. PubMed ID: 33158999
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Interaction and antiviral treatment of coinfection between SARS-CoV-2 and influenza in vitro.
    Liu D; Leung KY; Lam HY; Zhang R; Fan Y; Xie X; Chan KH; Hung IF
    Virus Res; 2024 Jul; 345():199371. PubMed ID: 38621598
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Investigating Viral Interference Between Influenza A Virus and Human Respiratory Syncytial Virus in a Ferret Model of Infection.
    Chan KF; Carolan LA; Korenkov D; Druce J; McCaw J; Reading PC; Barr IG; Laurie KL
    J Infect Dis; 2018 Jul; 218(3):406-417. PubMed ID: 29746640
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Usefulness of Ct value in acute respiratory infections caused by respiratory syncytial virus A and B and influenza virus A (H1N1)pdm09, A (H3N2) and B.
    Reina J; Morales C; Busquets M; Norte C
    Enferm Infecc Microbiol Clin (Engl Ed); 2018; 36(6):332-335. PubMed ID: 28601216
    [TBL] [Abstract][Full Text] [Related]  

  • 17. 4'-Fluorouridine mitigates lethal infection with pandemic human and highly pathogenic avian influenza viruses.
    Lieber CM; Aggarwal M; Yoon JJ; Cox RM; Kang HJ; Sourimant J; Toots M; Johnson SK; Jones CA; Sticher ZM; Kolykhalov AA; Saindane MT; Tompkins SM; Planz O; Painter GR; Natchus MG; Sakamoto K; Plemper RK
    PLoS Pathog; 2023 Apr; 19(4):e1011342. PubMed ID: 37068076
    [TBL] [Abstract][Full Text] [Related]  

  • 18. High prevalence of SARS-CoV-2 and influenza A virus (H1N1) coinfection in dead patients in Northeastern Iran.
    Hashemi SA; Safamanesh S; Ghasemzadeh-Moghaddam H; Ghafouri M; Azimian A
    J Med Virol; 2021 Feb; 93(2):1008-1012. PubMed ID: 32720703
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Human Nose Organoid Respiratory Virus Model: an
    Rajan A; Weaver AM; Aloisio GM; Jelinski J; Johnson HL; Venable SF; McBride T; Aideyan L; Piedra FA; Ye X; Melicoff-Portillo E; Yerramilli MRK; Zeng XL; Mancini MA; Stossi F; Maresso AW; Kotkar SA; Estes MK; Blutt S; Avadhanula V; Piedra PA
    mBio; 2021 Feb; 13(1):e0351121. PubMed ID: 35164569
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparative analysis of Respiratory Syncytial Virus frequency rates and viral load in different patient cohorts in a University Hospital in São Paulo, Brazil, over an eight-year period (2005-2013).
    de Souza Luna LK; Cruz JS; Chaves TDSS; Bellei N
    Braz J Infect Dis; 2023; 27(6):103702. PubMed ID: 38043582
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.